IL-13 Contributes to Drug Resistance of NK/T-Cell Lymphoma Cells by Regulating ABCC4

BioMed Research International - United States
doi 10.1155/2018/2606834
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Hindawi Limited

Related search

Deficient IL-2 Produced by Activated CD56+ T Cells Contributes to Impaired NK Cell-Mediated ADCC Function in Chronic HIV-1 Infection

Frontiers in Immunology
AllergyImmunology
2019English

Reactivation of Epstein-Barr Virus Hepatitis in T/Natural Killer (NK) Cells Mimicking Liver T/NK-Cell Lymphoma

Gastroenterology Research
2020English

Nk/T-Cell Lymphoma, the French Experience.

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

Extranodal NK/T Cell Lymphoma, Nasal Type

Trends in General Practice
2018English

S100A8 Contributes to Drug Resistance by Promoting Autophagy in Leukemia Cells

PLoS ONE
Multidisciplinary
2014English

The Role of IL-13 and NK T Cells in Experimental and Human Ulcerative Colitis

Mucosal Immunology
AllergyImmunology
2008English

A Case of Epiglottic NK/T Cell Malignant Lymphoma

Journal of Otolaryngology of Japan
Otorhinolaryngology
2011English

NK Cell‑produced IFN‑γ Regulates Cell Growth and Apoptosis of Colorectal Cancer by Regulating IL‑15

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2019English

KDM5B Promotes Drug Resistance by Regulating Melanoma Propagating Cell Subpopulations

Molecular Cancer Therapeutics
Cancer ResearchOncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy